Dr. William Werschler
Claim this profilePremier Clinical Research
Studies Atopic Dermatitis
Studies Eczema
5 reported clinical trials
6 drugs studied
Affiliated Hospitals
More about William Werschler
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments William Werschler has experience with
- Lebrikizumab
- Placebo
- DBI-001 Gel
- DBI-002 Gel
- Aqueous Gel
- Deucravacitinib
Breakdown of trials William Werschler has run
Atopic Dermatitis
Eczema
Athlete's Foot
Psoriasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does William Werschler specialize in?
William Werschler focuses on Atopic Dermatitis and Eczema. In particular, much of their work with Atopic Dermatitis has involved treating patients, or patients who are undergoing treatment.
Is William Werschler currently recruiting for clinical trials?
No, William Werschler is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that William Werschler has studied deeply?
Yes, William Werschler has studied treatments such as Lebrikizumab, Placebo, DBI-001 Gel.
What is the best way to schedule an appointment with William Werschler?
Apply for one of the trials that William Werschler is conducting.
What is the office address of William Werschler?
The office of William Werschler is located at: Premier Clinical Research, Spokane, Washington 99202 United States. This is the address for their practice at the Premier Clinical Research.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.